[1]
“The effectiveness of a fixed double combination (bisoprolol, perindopril) in patients with stable coronary artery disease and arterial hypertension different degrees”, UJC, vol. 28, no. 5, pp. 24–38, Jan. 2022, doi: 10.31928/1608-635X-2021.5.2438.